Abstract
Cultured human fibroblasts undergo senescence (a loss of replicative capacity) after a uniform, fixed number of ∼50 population doublings, commonly termed the Hayflick limit. It has been long known from clonal and other quantitative studies, however, that cells decline in replicative capacity from the time of explantation and do so in a stochastic manner, with a half-life of only ∼8 doublings. The apparent 50-cell doubling limit reflects the expansive propagation of the last surviving clone. The relevance of either figure to survival of cells in the body is questionable, given that stem cells in some renewing tissues undergo >1,000 divisions in a lifetime with no morphological sign of senescence. Oddly enough, these observations have had little if any effect on general acceptance of the Hayflick limit in its original form. The absence of telomerase in cultured human cells and the shortening of telomeres at each population doubling have suggested that telomere length acts as a mitotic clock that accounts for their limited lifespan. This concept assumed an iconic character with the report that ectopic expression of telomerase by a vector greatly extended the lifespan of human cells. That something similar might occur in vivo seemed consistent with initial reports that most human somatic tissues lack telomerase activity. More careful study, however, has revealed telomerase activity in stem cells and some dividing transit cells of many renewing tissues and even in dividing myocytes of repairing cardiac muscle. It now seems likely that telomerase is active in vivo where and when it is needed to maintain tissue integrity. Caution is recommended in applying telomerase inhibition to kill telomerase-expressing cancer cells, because it would probably damage stem cells in essential organs and even increase the likelihood of secondary cancers. The risk may be especially high in sun-exposed skin, where there are usually thousands of p53-mutant clones of keratinocytes predisposed to cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yates, F.E. & Benton, L.A. Loss of integration and resiliency with age: a dissipative destruction. in Handbook of Physiology. A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts (ed. Masoro, E.J.). 591–610 (Oxford University Press, New York, 1955).
Hayflick, L. & Moorhead, P. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961).
Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965).
Rohme, D. Evidence for a relationship between longevity of mammalian species and lifespans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad. Sci. USA 78, 5009–5013 (1981).
Rubin, H. Cell aging in vivo and in vitro. Mech. Ageing Dev. 98, 1–35 (1997).
Cristofalo, V.J. & Sharf, B.B. Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. Exp. Cell Res. 76, 419–427 (1973).
Martin, G.M., Sprague, C.A., Norwood, T.H. & Pendergrass, W.R. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J. Pathol. 74, 137–154 (1974).
Smith, J.R. & Hayflick, L. Variation in the life-span of clones derived from human diploid cell strains. J. Cell Biol. 62, 48–53 (1974).
Rabinovitch, P.S. Regulation of human fibroblast growth rate by both non-cycling cell fraction and transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry. Proc. Natl. Acad. Sci. USA 80, 2951–2955 (1983).
Pontén, J., Stein, W. & Shall, S. A quantitative analysis of the aging of human glial cells in culture. J. Cell. Physiol. 117, 342–352 (1983).
McCarron, M. et al. Effect of age on lymphocyte proliferation. Mech. Ageing Dev. 41, 211–218 (1987).
Potten, C.S. & Morris, R.J. Epithelial cells in vivo. J. Cell Sci. Suppl. 10, 45–62 (1988).
Severino, J., Allen, R.G., Balin, S., Balin, A. & Cristofalo, V.J. Is β-galactosidase staining a marker of senescence in vitro and in vivo? Exp. Cell Res. 257, 162–171 (2000).
Smith, J.R. & Whitney, J.R. Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science 207, 82–84 (1980).
Cristofalo, V.J., Allan, R.G., Pignolo, R.J., Martin, B.G. & Beck, J.C. Relationship between donor age and replicative lifespan in culture, a reevaluation. Proc. Natl. Acad. Sci. USA 95, 10614–10619 (1998).
Stanley, J.F., Pye, D. & MacGregor, A. Comparison of doubling numbers attained by cultured animal cells with life span of species. Nature 255, 158–159 (1975).
Greider, C.W. Cellular responses to telomere shortening: cellular senescence as a tumor suppressor mechanism. in The Harvey Lectures. (Wiley-Liss, New York, in press, 2002).
Soukupova, M., Holeckova, E. & Hnevkovsky, P. Changes of the latent period of explanted tissues during ontogenesis. in Aging in Cell and Tissue Culture (eds Holeckova, E. & Cristofalo, V.J.) pp.41–56 (Plenum Press, New York, 1970).
Cameron, I.L. Cell proliferation and renewal in aging mice. J. Gerontol. 27, 162–172 (1972).
Lesher, S., Fry, R.J.M. & Kohn, H.I. Age and the generation time of the mouse duodenal epithelial cell. Exp. Cell Res. 24, 334–343 (1961).
Fry, R.J.M., Tyler, S.A. & Lesher, S. Relationships between age and variability. in Radiation and Ageing (eds Lindop, P.J. & Sacher, G.A.). 43–55 (Taylor & Francis, Semmering, Austria, 1966).
Pendergrass, W.R., Li, Y., Jiang, D., Fei, R.G. & Wolf, N.S. Caloric restriction: conservation of cellular replicative capacity in vitro accompanies life-span extension in mice. Exp. Cell Res. 217, 309–316 (1995).
Schneider, E.L. & Mitsui, Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. USA 73, 3584–3588 (1976).
Olovnikov, A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. Theor. Biol. 41, 181–190 (1973).
Levy, M.Z., Allsopp, R.C., Futcher, A.B., Greider, C.W. & Harley, C.B. Telomere end replication problem and cell aging. J. Mol. Biol. 225, 951–960 (1992).
Harley, C.B., Vaziri, H., Counter, C.M. & Allsopp, R.C. The telomere hypothesis of cellular aging. Exp. Gerontol. 27, 375–382 (1992).
Counter, C.M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921–1929 (1992).
Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
Blackburn, E. Telomere states and cell fates. Nature 408, 53–56 (2000).
Yang, J. et al. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274, 26141–26148 (1999).
Zhu, J., Wang, H., Bishop, J.M. & Blackburn, E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96, 3723–3728 (1999).
Oullette, M.M. et al. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 275, 10072–10076 (2000).
Sherr, C.J. & De Pinho, R.A. Cellular senescence: mitotic clock or culture shock. Cell 102, 407–410 (2000).
Tang, D.G., Takumoto, Y.M., Apperly, J.A., Lloyd, A.C. & Raff, M.C. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291, 868–871 (2001).
Mathon, N.F., Malcolm, D.S., Harrisingh, M.C., Cheng, L. & Lloyd, A.C. Lack of replicative senescence in normal rodent glia. Science 291, 872–875 (2001).
Shay, J. & Wright, W.E. When do telomeres matter? Science 291, 839–840 (2001).
Rubin, H. Telomerase and cellular lifespan: ending the debate? Nat. Biotechnol. 16, 396–397 (1998).
Rubin, H. Harry Rubin replies. Nat. Biotechnol. 17, 313–314 (1999).
Prowse, K.R. & Greider, C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818–4822 (1995).
Kim, N.W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
Bryan, T.M., Englezon, A., Gupta, J., Bacchetti, S. & Reddel, R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240–4248 (1995).
Kang, M.K., Guo, W. & Park, N.-H. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Diff. 9, 85–95 (1998).
Brown, J.P., Wei, W. & Sedivy, J.M. Bypass of senescence after disruption of p21 CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831–834 (1997).
Sugrue, M.M., Shin, D.Y., Lee, S.W. & Aaronson, S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA 94, 9648–9653 (1997).
Broccoli, D., Young, J.W. & de Lange, T. Telomerase in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92, 9083–9086 (1995).
Counter, C.M., Gupta, J., Harley, C.B., Leber, B. & Bacchetti, S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85, 2315–2320 (1995).
Hiyama, K. et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155, 3711–3715 (1995).
Buchkovich, K.J. & Greider, C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 7, 1443–1454 (1995).
Kyo, S., Takakura, M., Kohama, T. & Masaki, I. Telomerase activity in human endometrium. Cancer Res. 57, 610–614 (1997).
Belair, C.D., Yeager, T.R., Lopez, P.M. & Reznikoff, C.A. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677–13682 (1997).
Yasumoto, S. et al. Telomerase activity in normal epithelial cells. Oncogene 13, 433–439 (1996).
Jones, P.H. & Watt, F.M. Stem cell patterning and fate in human epidermis. Cell 80, 83–93 (1995).
Harle-Bachor, C. & Boukamp, P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93, 6476–6481 (1996).
Ramirez, R.D., Wright, W.E., Shay, J.W. & Taylor, R.S. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol. 198, 113–117 (1997).
Cotsarelis, G., Sun, T.-T. & Lavker, R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 1329–1337 (1990).
Hiyama, E. et al. Telomerase activity in human intestine. Intl. J. Oncology 9, 453–458 (1996).
Leri, A. et al. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc. Natl. Acad. Sci. USA 98, 8626–8631 (2001).
Greider, C.W. Telomerase activity, cell proliferation and cancer. Proc. Natl. Acad. Sci. USA 95, 90–92 (1998).
Venkatesan, R.N. & Price, C. Telomerase expression in chickens: constitutive activity in somatic tissues and down regulation in culture. Proc. Natl. Acad. Sci. USA 95, 14763–14768 (1998).
Lieberman, I. & Ove, P. Enzyme activity levels in mammalian cell cultures. J. Biol. Chem. 233, 634–636 (1958).
Burlington, H. Enzyme patterns in cultured kidney cells. Am. J. Physiol. 197, 68–70 (1959).
Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).
Allsopp, R.C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114–10118 (1992).
Frenck, R.W., Blackburn, E.H. & Shannon, K.M. The rate of telomerase sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA 95, 5607–5610 (1998).
Kveiborg, M. et al. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech. Ageing Dev. 106, 261–271 (1999).
Wright, N. & Alison, M. The Biology of Epithelial Cell Populations (Clarendon Press, Oxford; 1984).
Potten, C.S., Wichmann, H.E., Loeffler, M., Dobek, K. & Major, D. Evidence for discrete cell kinetic subpopulations in mouse epidermis based on mathematical analysis. Cell Tiss. Kinet. 15, 305–329 (1982).
Morris, R.J., Fischer, S.M. & Slaga, T.J. Evidence that centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J. Invest. Dermatol. 84, 277–281 (1985).
de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518–527 (1990).
Hastie, N.D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990).
Vulliamy, T.J., Knight, S.W., Mason, P.J. & Dokal, I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27, 353–357 (2001).
Vulliamy, T.J. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001).
Marciniak, R. & Guarente, L. Testing telomerase. Nature 413, 370–372 (2001).
Harley, C.B. et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp. Quant. Biol. 59, 307–315 (1994).
Holt, S.E., Wright, W.E. & Shay, J.W. Multiple pathways for the regulation of telomerase activity. Eur. J. Cancer 33, 761–766 (1997).
Blasco, M.A. et al. Telomere shortening and tumor formation by mouse fibroblasts lacking telomerase RNA. Cell 91, 25–34 (1997).
Rudolph, K.L. et al. Longevity, stress response and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999).
Artandi, S.E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
Jonason, A.S. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA 93, 14025–14029 (1996).
Zhang, W., Remenyik, E., Zelterman, D., Brash, D.E. & Wikonkai, N.M. Escaping the stem cell compartment: sustained UVB exposure allows mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc. Natl. Acad. Sci. USA 98, 13948–13953 (2001).
Naasani, I., Seimiya, H., Yamori, T. & Tsuruo, T. FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res. 59, 4004–4011 (1999).
Kondo, S., Kondo, Y., Li, G., Silverman, R.H. & Cowell, J.K. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16, 3323–3330 (1998).
Hahn, W.C. et al. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164–1170 (1999).
Zhang, X., Mar, V., Zhou, W., Harrington, L. & Robinson, M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388–2399 (1999).
Kim, M.M. et al. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation. Proc. Natl. Acad. Sci. USA 98, 7982–7987 (2001).
Todaro, G.J. & Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299–313 (1963).
Merz, G.S., Jr. & Ross, J.D. Clone size variation in the human diploid cell strain W1–38. J. Cell Physiol. 82, 75–80 (1973).
Absher, P.M. & Absher, R.G. Clonal variation and aging of diploid fibroblasts. Exp. Cell Res. 103, 247–255 (1976).
Wright, W.E. & Shay, J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383–389 (1992).
Holliday, R. Endless quest. BioEssays 18, 3–5 (1996).
Martin, G.M., Sprague, C.A., & Epstein, C.J. Replicative lifespan of cultivated human cells: effect of donor age, tissue and genotype. Lab. Invest. 23, 86–92 (1970).
Rubin, H. Rubin replies. Nat. Biotechnol. 16, 702 (1998).
de Lange, T. Telomeres and senescence: ending the debate. Science 279, 334–335 (1998).
Weinrich, S.L. et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498–502 (1997).
Zijlmans, J.M. et al. Telomeres in mouse have large interchromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. USA 94, 7423–7428 (1997).
Hemann, M.T. & Greider, C. Wild-derived inbred mouse strains have short telomeres. Nucleic Acid Res. 28, 4474–4478 (2000).
Robbins, E., Levine, E.M. & Eagle, H. Morphological changes accompanying senescence of cultured human diploid cells. J. Exp. Med. 131, 1211–1222 (1970).
Hart, R.W. & Setlow, R.B. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc. Natl. Acad. Sci. USA 71, 2169–2173 (1974).
Hamilton, M.L. et al. Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA. 98, 10469–10474 (2001).
Acknowledgements
Valuable comments on the manuscript were made by Elizabeth Blackburn, Kathleen Collins, Vincent Cristofalo, Peter Rabinovitch, and Kevin Shannon. Dorothy Rubin transcribed and helped edit the manuscript. The research was supported by the Elsasser Family Fund and by National Institutes of Health grant DI3LM07483..
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rubin, H. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol 20, 675–681 (2002). https://doi.org/10.1038/nbt0702-675
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0702-675
This article is cited by
-
Functional T cells are capable of supernumerary cell division and longevity
Nature (2023)
-
Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence
Molecular Biology Reports (2022)
-
Loss of developmental pluripotency occurs in two stages during leaf aging in Arabidopsis thaliana
In Vitro Cellular & Developmental Biology - Plant (2017)
-
The co-expression of telomerase and ALT pathway in human breast cancer tissues
Tumor Biology (2014)